Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProGenTech was a molecular diagnostics company that developed automated, integrated systems for nucleic acid extraction and analysis. Its core technology, the Entos platform, utilized proprietary microfluidic cassettes to automate complex laboratory workflows, making molecular testing more accessible and efficient. The company operated with a dual-base model, maintaining headquarters in Emeryville, California, and research and manufacturing facilities in Shanghai, China. In October 2010, ProGenTech was acquired by Luminex Corporation, which integrated ProGenTech's microfluidic technology into its own diagnostic portfolio. The acquisition was valued at approximately $10 million in cash plus potential future milestone payments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProGenTech.